Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,694
Total Claims
$2.1M
Drug Cost
739
Beneficiaries
$2,789
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+137%
Cost per patient vs peers
$2,789 vs $1,174 avg
+149%
Brand preference vs peers
22.0% vs 8.9% avg
Brand vs Generic
Brand: 2,734 claims · $1.7M
Generic: 9,669 claims · $308K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Icosapent Ethyl | 773 | $390K |
| Diclofenac Epolamine | 306 | $217K |
| Tenofovir Alafenamide | 100 | $173K |
| Empagliflozin | 137 | $120K |
| Sitagliptin Phosphate | 145 | $118K |
| Dapagliflozin Propanediol | 125 | $99K |
| Denosumab | 51 | $88K |
| Apixaban | 70 | $55K |
| Icosapent Ethyl | 84 | $48K |
| Linagliptin | 58 | $37K |
| Metformin Hcl | 12 | $36K |
| Sitagliptin Phos/Metformin Hcl | 35 | $34K |
| Linaclotide | 48 | $30K |
| Semaglutide | 24 | $28K |
| Diclofenac Sodium | 195 | $28K |
Prescribing Profile
Patient Profile
73
Avg Age
52%
Female
1.08
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data